期刊文献+

SYNTAX积分与急性心肌梗死急诊介入治疗后心血管事件的关系 被引量:10

SYNTAX score and cardiovascular events in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
下载PDF
导出
摘要 目的:探讨SYNTAX积分对急性ST段抬高型心肌梗死(STEMI)患者急诊介入治疗术后院内及1年预后的预测作用。方法:连续纳入因急性STEMI行急诊经皮冠状动脉介入治疗(PCI)的患者共312例,根据冠状动脉造影结果计算SYNTAX积分后分为3组,A组170例为基线SYNTAX积分(bSSC)〈22分;B组90例,bSSC=22~32分;C组52例,bSSC〉32分。结果:(1)B组、C组与A组比较,合并糖尿病患者的比例较高,肌酸激酶同工酶(CK—MB)、尿酸(UA)及空腹血糖水平较高,差异有统计学意义,P〈0.05。(2)A、B、C3组患者院内严重不良心血管事件发生的比例分别是6.6%(n=11)、31.1%(n=28)、36.5%(n=19),差异有统计学意义,P〈0.05。(3)入选患者平均随访(14.2±0.8)月,Kaplan—Meier生存分析显示,3组主要不良心血管事件(MACE)、全因死亡、非致死性心肌梗死、非计划再次PCI、因心力衰竭发作入院治疗的累积事件发生率有显著差异,log-rankP〈0.001。(4)多因素Cox回归分析显示,bSSC(HR=1.059,95%CI:1.035~1.083,P〈0.001)、剩余SYNTAX积分(rSSC)(HR=1.056,95%CI:1.033~1.081.P〈0.001)是STEMI患者急诊PCI术后MACE的独立预测因子。结论:院内及随访结果显示bSSC是STEMI患者急诊PCI术后MACE的独立预测因子。 Objective: To investigate the predictive effect of SYNTAX score for in-hospital and one-year prognosis outcome in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Methods:A total of 312 patients with STEMI undergoing primary PCI were divided into three groups based on SYNTAX scores which were calculated by angiography results. Group A (n=170) was defined as baseline SYNTAX score (bSSC) 〈22, group B bSSC=22-32 (n=90), group C bSSC〉32 (n=52). Results:(1) Group B and group C had a higher proportion of patients with diabetes, a higher CK-MB, UA, fasting glucose compared with group A (P〈0.05). (2) The proportions of patients with severe adverse cardiovascular events in-hospital in three groups were 6.6% (n= 11), 31.1% (n=28), 36.5% (n=19) respectively (P〈0.05). (3) For patients whose follow-up periods were (14.2±0.8) months, Kaplan-Meier survival analysis showed log-rank P〈0.O01 was found among major adverse cardiovascular events (MACE), all-cause death, non-fatal MI, unplanned revascularization for ischemia, rehospitalization due to heart failure. (4) By muhivariable analysis, bSSC and rSSC were found to be significant independent predictor for all ischemie outcomes at year 1, including MACE (HR=l.059, 95%CI: 1.035-1.083, P〈0.001; HR= 1.056, 95%CI: 1.033-1.081, P〈0.001). Conclusion:The SYNTAX score is an independent predictor for in-hospital as well as long-term mortality and MACE in patients with acute STEMI undergoing primary PCI.
出处 《天津医科大学学报》 2015年第1期43-47,共5页 Journal of Tianjin Medical University
关键词 冠状动脉疾病 急性ST段抬高型心肌梗死 SYNTAX积分 冠状动脉造影 经皮冠状动脉介入治疗 coronary artery disease acute ST-segment elevation myocardial infarction SYNTAX score cardioangiography percutaneous coronary intervention
  • 相关文献

参考文献16

  • 1R?ber L, Kelb?k H, Ostojic M, et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial[J]. JAMA, 2012,308(8):777.
  • 2Bonnefoy E, Kirkorian G. Mortality of myocardial infarction[J]. Ann Cardiol Angiol(Paris), 2011,60:311.
  • 3Sianos G, Morel M A, Kappetein A P, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease[J]. EuroIntervention, 2005,1(2):219.
  • 4Serruys P W, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study[J]. EuroIntervention, 2009,5(1):50.
  • 5Généreux P, Palmerini T, Caixeta A, et al. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score[J]. J Am Coll Cardiol, 2012,59(24):2165.
  • 6Capodanno D. Beyond the SYNTAX score--advantages and limitations of other risk assessment systems in left main percutaneous coronary intervention[J]. Circ J, 2013,77(5):1131.
  • 7Farooq V, Head S J, Kappetein A P, et al. Widening clinical applications of the SYNTAX Score[J]. Heart, 2014,100(4):276.
  • 8Head S J, Farooq V, Serruys P W, et al. The SYNTAX score and its clinical implications[J]. Heart, 2014,100(2):169.
  • 9Akgun T, Oduncu V, Bitigen A, et al. Baseline SYNTAX score and Long-Term outcome in patients with ST-Segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Clin Appl Thromb Hemost, 2014.
  • 10Yang C H, Hsieh M J, Chen C C, et al. SYNTAX score: an Independent predictor of long-term cardiac mortality in patients with acute ST-elevation myocardial infarction[J]. Coron Artery Dis, 2012,23(7):445.

二级参考文献4

共引文献1973

同被引文献90

  • 1芮浩淼,齐超,吴长燕.冠脉造影SYNTAX积分对老年冠心病患者经皮冠状动脉介入治疗预后的预测作用[J].中国老年学杂志,2014,34(1):85-86. 被引量:11
  • 2周滔,杨德光,陈小芳,肖孟,潜学勤.红细胞膜胆固醇水平与非ST抬高型急性冠状动脉综合征患者PCI相关冠状动脉慢血流或无复流发生相关[J].中国动脉硬化杂志,2015,23(4):379-383. 被引量:11
  • 3Raber L, Kelbaek H, Ostojic M, et al. Effect of biolimus-elut- ing stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocar- dial infarction: the comfortable AMI randomized trial [J]. JA- MA, 2012, 308(8):777-787.
  • 4Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease [J]. N Engl J Med, 2009, 360(10):961-972.
  • 5Sinning C, Lillpopp L, Appelbaam S, et al. Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application [J]. Clin Res Cardiol, 2013, 102(7):495-503.
  • 6Worner F, A Cequier, A Bardaji, et al. Comments on the ESC Guidelines for the Management of Acute Myocardial In- farction in Patients Presenting With ST-Segment Elevation [J]. Rev Esp Cardiol (Engl Ed), 2013, 66(1):5-11.
  • 7Head SJ, V Farooq, PW Senuys, et al. The SYNTAX score and its clinical implications [J]. Heart, 2014, 100(2):169- 177.
  • 8Garg S G Sarno, PW Serruys, et al. Prediction of 1-year clin- ical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergo-mg primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATE- GY (Muhicenter Evaluation of Single High-Dose Bolus Tiro- fiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials [J]. JACC Cardiovasc Interv, 2011, 4(1):66-75.
  • 9Wijns W, P Kolh, N Danchin, et al. Guidelines on myocardi- al revascularization [J]. Eur Heart J, 2010, 31(20):2501- 2555.
  • 10Levine GN, ER Bates, JC Blankenship, et al. 2011 ACCF/ AHA/SCA1 Guideline for Percutaneous Coronary Interven- tion: a report of the American College of Cardiology Founda- tion/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [J]. Circulation, 2011,124 (23): e574-651.

引证文献10

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部